McKesson Opens Its Most Technologically Advanced Healthcare Distribution Center in Jeffersonville, Ohio
IRVING, TX, Oct. 26, 2022 — McKesson Corporation has opened a new state-of-the-art pharmaceutical distribution center in Jeffersonville, Ohio, centrally located between Cincinnati and Columbus. The new facility will distribute pharmaceutical, over-the-counter (OTC) and home healthcare (HHC) products... (Source: McKesson News)
Source: McKesson News - October 26, 2022 Category: Information Technology Source Type: news

McKesson Thought Leaders Are Key Presenters at 2022 Association for Value-Based Cancer Care Summit
IRVING, Texas, Oct. 18, 2022 — Thought leaders from McKesson will play a major role in the upcoming 2022 Association for Value-Based Cancer Care (AVBCC) Summit, speaking on a wide range of topics that showcase their extensive knowledge of the changing healthcare landscape and oncology’s transformati... (Source: McKesson News)
Source: McKesson News - October 18, 2022 Category: Information Technology Source Type: news

McKesson Corporation Extends Pharmaceutical Distribution Agreement with CVS Health
IRVING, Texas, September 29, 2022 —McKesson Corporation (NYSE: MCK) today announced that it has signed an agreement in principle to extend its partnership with CVS Health to distribute pharmaceuticals to mail order and specialty pharmacies, retail pharmacies and distribution centers through June 2027... (Source: McKesson News)
Source: McKesson News - September 29, 2022 Category: Information Technology Source Type: news

McKesson Signs Agreement to Acquire Rx Savings Solutions
Acquisition extends leadership in access, affordability, and adherence solutions, leveraging McKesson ’s differentiated platformAcquisition of Rx Savings Solutions strengthens McKesson’s purpose to advance health outcomes for allMcKesson and Rx Savings Solutions share a commitment to making medicatio... (Source: McKesson News)
Source: McKesson News - September 19, 2022 Category: Information Technology Source Type: news

McKesson Names LeAnn B. Smith as Next Chief Human Resources Officer
IRVING, Texas, September 13, 2022 —McKesson Corporation (NYSE:MCK) today announced that LeAnn B. Smith has been selected to become executive vice president and chief human resources officer (CHRO). Ms. Smith will succeed Tracy L. Faber, McKesson’s current CHRO, who will be retiring after an accomplis... (Source: McKesson News)
Source: McKesson News - September 13, 2022 Category: Information Technology Source Type: news

McKesson Medical-Surgical Supports National Health Center Week 2022
RICHMOND, VA —McKesson Medical-Surgical, an affiliate of the McKesson Corporation, will be participating as a silver sponsor of National Association of Community Health Center National Health Center Week 2022 (NHCW) August 7-13. The theme of NHCW 2022 is “Community Health Centers: The Chemistry for S... (Source: McKesson News)
Source: McKesson News - August 4, 2022 Category: Information Technology Source Type: news

McKesson Corporation Reports Fiscal 2023 First-Quarter Results
First-Quarter Highlights: (Source: McKesson News)
Source: McKesson News - August 3, 2022 Category: Information Technology Source Type: news

Biologics by McKesson is now the Exclusive Specialty Pharmacy Provider of XERMELO (telotristat ethyl), an FDA Approved Therapy for Carcinoid Syndrome Diarrhea
CARY, N.C., July 25, 2022 —Biologics by McKesson, an independent specialty pharmacy focused on oncology and rare disease areas, has been selected by TerSera Therapeutics LLC, as the exclusive specialty pharmacy provider for XERMELO® (telotristat ethyl), effective Sept. 1, 2022. XERMELO is used for t... (Source: McKesson News)
Source: McKesson News - July 25, 2022 Category: Information Technology Source Type: news

McKesson Raises Quarterly Dividend by 15% to $0.54 Per Share
IRVING, Texas, July 25, 2022 —The Board of Directors of McKesson Corporation (NYSE:MCK) declared on July 22, 2022 a regular dividend of $0.54 per share of common stock, a 15% increase from $0.47 per share in the prior quarter. The dividend will be payable on October 3, 2022, to stockholders of record... (Source: McKesson News)
Source: McKesson News - July 25, 2022 Category: Information Technology Source Type: news

McKesson Earns Top Score as One of the Best Places to Work for Disability Inclusion
IRVING, Texas, July 20, 2022 — For the seventh consecutive year, McKesson is honored as one of the “Best Places to Work for Disability Inclusion” by Disability Equality Index (DEI). McKesson earned a top score of 100% for the fourth year in a row by creating an open and inclusive culture for all tea... (Source: McKesson News)
Source: McKesson News - July 20, 2022 Category: Information Technology Source Type: news

McKesson ideaShare Conference Draws Attendees From More Than 2,100 Independent Pharmacies to First In-Person Conference Since 2019
2022 Conference Developed by McKesson and Health Mart Focuses on “Charting the Future of Community Pharmacy” Health Mart Pharmacy of the Year and Innovation Awards Also Presented During the Conference (Source: McKesson News)
Source: McKesson News - July 12, 2022 Category: Information Technology Source Type: news

McKesson Corporation Announces First Quarter Fiscal 2023 Earnings Release Date
IRVING, Texas, June 29, 2022 -- McKesson Corporation (NYSE: MCK) will release its first quarter fiscal 2023 financial results after market close on Wednesday, August 3, 2022. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its fina... (Source: McKesson News)
Source: McKesson News - June 29, 2022 Category: Information Technology Source Type: news

McKesson and HCA Healthcare Announce Plans to Form an Oncology Research Joint Venture to Advance Cancer Care and Increase Access to Oncology Clinical
IRVING, TX& NASHVILLE, Tenn., June 23, 2022 – McKesson Corporation (NYSE: MCK) and HCA Healthcare, Inc. (NYSE: HCA) announced today an agreement to form a joint venture combining McKesson’s US Oncology Research (USOR) and HCA Healthcare’s Sarah Cannon Research Institute (SCRI). USOR is the research... (Source: McKesson News)
Source: McKesson News - June 23, 2022 Category: Information Technology Source Type: news

New MYLUNG Consortium Research Demonstrates Remote Pharmacist Intervention Significantly Increases Clinical Trial Enrollments in Community Oncology Setting
Average monthly enrollment nearly doubled with pharmacy interventionRemote pharmacist easily adapted into clinic workflows in community practices (Source: McKesson News)
Source: McKesson News - June 6, 2022 Category: Information Technology Source Type: news

Investigators from US Oncology Research, The US Oncology Network and Ontada Present Data Highlighting Key Advances and Insights at the 2022 American Society of Clinical Oncology Annual Meeting
THE WOODLANDS, Texas, June 3, 2022 — During the scientific program of the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, principal investigators from US Oncology Research, The US Oncology Network (The Network) and Ontada® will present detailed results from more than 80 studies. Pr... (Source: McKesson News)
Source: McKesson News - June 3, 2022 Category: Information Technology Source Type: news